Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Troy, MI
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Troy, MI
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Minneapolis, MN
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
St. Louis, MO
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Edison, NJ
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Edison, NJ
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Endwell, NY
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Endwell, NY
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Greensboro, NC
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Winston-Salem, NC
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Cincinnati, OH
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Cincinnati, OH
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Lyndhurst, OH
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Lyndhurst, OH
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
West Chester, OH
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
West Chester, OH
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Portland, OR
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Philadelphia, PA
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Pittsburgh, PA
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Uniontown, PA
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Uniontown, PA
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Warwick, RI
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Chattanooga, TN
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Kingsport, TN
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
San Antonio, TX
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Corpus Christi, TX
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Houston, TX
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Houston, TX
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  9/20/2012
Clinical Research Facility
mi
from
Lake Jackson, TX
A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 9/20/2012
Clinical Research Facility
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers
A Randomized, Placebo Controlled, Double-Blind, Third Party Open, Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Female Adult Volunteers
Status: Enrolling
Updated:  9/28/2012
Pfizer Investigational Site
mi
from
Atlantis, FL
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers
A Randomized, Placebo Controlled, Double-Blind, Third Party Open, Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Female Adult Volunteers
Status: Enrolling
Updated: 9/28/2012
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers
A Randomized, Placebo Controlled, Double-Blind, Third Party Open, Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Female Adult Volunteers
Status: Enrolling
Updated:  9/28/2012
Pfizer Investigational Site
mi
from
Houston, TX
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers
A Randomized, Placebo Controlled, Double-Blind, Third Party Open, Ascending Dose Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Female Adult Volunteers
Status: Enrolling
Updated: 9/28/2012
Pfizer Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Paradise Valley, AZ
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Paradise Valley, AZ
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Redondo Beach, CA
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
San Francisco, CA
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Jacksonville, FL
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Miami, FL
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Sarasota, FL
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Ocala, FL
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Fort Wayne, IN
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Boston, MA
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Springfield, MO
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
St. Louis, MO
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Rochester, NY
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Akron, OH
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Cleveland, OH
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Nashville, TN
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Houston, TX
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
South Jordan, UT
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
South Jordan, UT
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Henrico, VA
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Henrico, VA
Click here to add this to my saved trials
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated:  10/10/2012
Clinical Research Facility
mi
from
Richmond, VA
A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007 AM1)
A Phase IIb, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Will the Use of Osteopathic Manipulative Treatments Help Alleviate Headache Pain
Will the Use of Osteopathic Manipulative Treatments on Patients With Headache in the Emergency Department Result in Decreased Pain on 100 Point Pain Scale?
Status: Enrolling
Updated:  10/10/2012
Good Samaritan Hospital Medical Center
mi
from
West Islip, NY
Will the Use of Osteopathic Manipulative Treatments Help Alleviate Headache Pain
Will the Use of Osteopathic Manipulative Treatments on Patients With Headache in the Emergency Department Result in Decreased Pain on 100 Point Pain Scale?
Status: Enrolling
Updated: 10/10/2012
Good Samaritan Hospital Medical Center
mi
from
West Islip, NY
Click here to add this to my saved trials